Prostate Cancer Survey

Completed

Conditions studied: Prostate Cancer

In brief

There have been calls from patients, payers, healthcare providers, and policy makers for an evaluation of newer, high-cost radiation technologies compared to conventional forms of radiation therapy. National attention has focused on the use of intensity modulated radiation therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation. The analysis will be performed by obtaining patient answered surveys looking at side effects.

Key facts

Study ID

NCT03128710

Run by

University of Maryland, Baltimore

People needed

224

Starts

2017-03-15

Expected to finish

2018-02-15

Last updated by the study team

2024-11-05

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Participant is 18 years or older
• Has been diagnosed with prostate cancer
• Able to speak and read English

You may not qualify if…

• Participant is not being seen for prostate cancer
• Under the age of 18

Where it is running

• UMMC — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.